Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Tolerability of Long-term Administration of OROS Hydromorphone HCI (Slow Release) in Cancer Pain
This study has been completed.
Study NCT00410787   Information provided by Alza Corporation, DE, USA

First Received on December 12, 2006.   Last Updated on April 26, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial